Inventor · disambiguated record
Deping Wang
Also filed as: WANG DEPING
35 granted patents·26 pending applications·263 citations·filing 2003–2025
97Inventor score
Files withMERCK SHARP & DOHME10RIB X PHARMACEUTICALS INC9BIOGEN MA INC6SUNESIS PHARMACEUTICALS INC5BIOVERATIV THERAPEUTICS INC4
Top patents by PatentIndex Score
61 records- 0194US7148219B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2005·Granted Dec 12, 2006·28 cites·71 claims
- 0293US6969726B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2004·Granted Nov 29, 2005·44 cites·104 claims
- 0392US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0491US10421798B2Factor VIII compositions and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2012·Granted Sep 24, 2019·16 cites·44 claims
- 0591US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 0690US7335753B2Bifunctional heterocyclic compounds and methods of making and using sameRIB X PHARMACEUTICALS INC·Filed 2006·Granted Feb 26, 2008·18 cites·21 claims
- 0789US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 0889US7456206B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2006·Granted Nov 25, 2008·8 cites·14 claims
- 0988US7129259B2Halogenated biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2004·Granted Oct 31, 2006·31 cites·111 claims
- 1087US7705026B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2008·Granted Apr 27, 2010·5 cites·14 claims
- 1186US8846671B2Heterocyclic alkynyl benzene compounds and medical compositions and uses thereofDING KE·Filed 2011·Granted Sep 30, 2014·11 cites·11 claims
- 1285US9555050B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 31, 2017·4 cites·24 claims
- 1384US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 1484US7091196B2Bifunctional heterocyclic compounds and methods of making and using sameRIB X PHARMACEUTICALS INC·Filed 2003·Granted Aug 15, 2006·21 cites·23 claims
- 1584US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1684US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1783US9273028B2Heterocyclic tyrosine kinase inhibitorsHOPKINS BRIAN T·Filed 2011·Granted Mar 1, 2016·6 cites·8 claims
- 1882US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 1982US9522889B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 20, 2016·5 cites·31 claims
- 2080US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 2179US11066396B23-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jul 20, 2021·2 cites·9 claims
- 2278US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2377US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2476US8202843B2Macrocyclic compounds and methods of making and using the sameFARMER JAY J·Filed 2005·Granted Jun 19, 2012·2 cites·16 claims
- 2575US2023322900A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2675US2023019286A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2774US10160762B26-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 25, 2018·2 cites·17 claims
- 2872US10519147B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Dec 31, 2019·1 cites·18 claims
- 2972US10221167B2Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·1 cites·46 claims
- 3070US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 3170US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3270US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3369US2019315835A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3467US2015038421A1Factor viii compositions and methods of making and using sameAMUNIX OPERATING INC·Filed 2014·Application pending·0 cites
- 3565US9550783B2Biaryl heterocyclic compounds and methods of making and using the sameMELINTA THERAPEUTICS INC·Filed 2014·Granted Jan 24, 2017·0 cites·17 claims
- 3664US2016376344A1Factor viii compositions and methods of making and using sameAMUNIX OPERATING INC·Filed 2016·Application pending·0 cites
- 3763US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3862US2014073624A1Biaryl Heterocyclic Compounds and Methods of Making and Using the SameRIB X PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3960US2015158901A1Macrocyclic compounds and methods of making and using the sameMELINTA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4060US2025214962A1Pyridinone derivatives as selective cytotoxic agents against hiv infected cellsMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 4160US2013017997A1Factor VIII Compositions and Methods of Making and Using SameAMUNIX OPERATING INC·Filed 2012·Application pending·0 cites
- 4259US2012010200A1Biaryl Heterocyclic Compounds And Methods Of Making And Using The SameZHOU JIACHENG·Filed 2011·Application pending·0 cites
- 4358US2020087379A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4457US12492183B2Tetrahydroquinazoline derivatives as selective cytotoxic agentsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·25 claims
- 4556US8841263B2Macrocyclic compounds and methods of making and using the sameFARMER JAY J·Filed 2012·Granted Sep 23, 2014·0 cites·3 claims
- 4656US2018066007A1Macrocyclic Compounds And Methods Of Making And Using The SameMELINTA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4756US2010234591A1Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4855US2008119419A1Bifunctional heterocyclic compounds and methods of making and using sameWANG DEPING·Filed 2007·Application pending·0 cites
- 4953US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 5052US2016039825A1S1p and/or atx modulating agentsBIOGEN MA INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Deping Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →